These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 31677618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.
    Parta M, Hilligoss D, Kelly C, Kwatemaa N, Theobald N, Zerbe CS, Holland SM, Malech HL, Kang EM.
    J Clin Immunol; 2020 May; 40(4):619-624. PubMed ID: 32314173
    [Abstract] [Full Text] [Related]

  • 4. Haploidentical stem cell transplantation in a boy with chronic granulomatous disease.
    Regueiro-García A, Fariña-Nogueira S, Porto-Arceo JÁ, Couselo-Sánchez JM.
    Allergol Immunopathol (Madr); 2018 May; 46(4):385-388. PubMed ID: 29373243
    [Abstract] [Full Text] [Related]

  • 5. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
    Sharma A, Rastogi N, Kapoor R, Chatterjee G, Yadav SP.
    J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e230-e233. PubMed ID: 32459721
    [Abstract] [Full Text] [Related]

  • 6. Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease.
    Zhou L, Dong LJ, Gao ZY, Yu XJ, Lu DP.
    Pediatr Transplant; 2017 Feb 01; 21(1):. PubMed ID: 27885760
    [Abstract] [Full Text] [Related]

  • 7. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V, Hütker S, Schmid I, Immler S, Feuchtinger T, Albert MH.
    Ann Hematol; 2017 Aug 01; 96(8):1373-1377. PubMed ID: 28573314
    [Abstract] [Full Text] [Related]

  • 8. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India.
    Uppuluri R, Swaminathan VV, Ramanan KM, Meena S, Varla H, Ramakrishnan B, Jayakumar I, Raj R.
    Biol Blood Marrow Transplant; 2020 Dec 01; 26(12):2292-2298. PubMed ID: 32835780
    [Abstract] [Full Text] [Related]

  • 9. Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major.
    Vellaichamy Swaminathan V, Ravichandran N, Ramanan KM, Meena SK, Varla H, Ramakrishnan B, Jayakumar I, Uppuluri R, Raj R.
    Pediatr Transplant; 2021 Mar 01; 25(2):e13893. PubMed ID: 33111490
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X, Liu L, Xie Z, Dong C, Zhao L, Zhang J, Gu J, Zhu HH.
    Crit Rev Oncol Hematol; 2019 Jan 01; 133():120-128. PubMed ID: 30661648
    [Abstract] [Full Text] [Related]

  • 11. Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies.
    Law AD, Salas MQ, Lam W, Michelis FV, Thyagu S, Kim DDH, Lipton JH, Kumar R, Messner H, Viswabandya A.
    Biol Blood Marrow Transplant; 2018 Nov 01; 24(11):2259-2264. PubMed ID: 30009980
    [Abstract] [Full Text] [Related]

  • 12. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
    Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, Moreira B, Fremond ML, Briand C, Bendavid M, Levy R, Morelle G, Vincent M, Magrin E, Bourget P, Chatenoud L, Picard C, Fischer A, Moshous D, Blanche S.
    Biol Blood Marrow Transplant; 2019 Jul 01; 25(7):1363-1373. PubMed ID: 30876929
    [Abstract] [Full Text] [Related]

  • 13. Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease.
    Scheiermann J, Künkele A, von Stackelberg A, Eggert A, Lang P, Zirngibl F, Martin L, Schulte JH, von Bernuth H.
    Front Immunol; 2023 Jul 01; 14():1042650. PubMed ID: 36875143
    [Abstract] [Full Text] [Related]

  • 14. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N, Greco R, Crucitti L, Morelli M, Giglio F, Levati G, Assanelli A, Carrabba MG, Bellio L, Milani R, Lorentino F, Stanghellini MT, De Freitas T, Marktel S, Bernardi M, Corti C, Vago L, Bonini C, Ciceri F, Peccatori J.
    Biol Blood Marrow Transplant; 2015 Aug 01; 21(8):1506-14. PubMed ID: 26001696
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.
    Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I, Kalwak K, Talano JA, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo ME, Veys P, Sykora KW, Gennery AR, Slatter M.
    Blood; 2016 Jul 21; 128(3):440-8. PubMed ID: 27216217
    [Abstract] [Full Text] [Related]

  • 18. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis.
    Kohli S, Rastogi N, Nivargi S, Thakkar D, Katewa S, Yadav SP.
    J Pediatr Hematol Oncol; 2019 Apr 21; 41(3):e158-e160. PubMed ID: 30044345
    [Abstract] [Full Text] [Related]

  • 19. [Clinical Efficacy of Haplo-HSCT of ATG Combined with PTCy for Children with Myelodysplastic Syndrome].
    Song ZL, Liu R, Hu T, Li JH, Zhang CX, Zhang L, Zhong DX, Yue M, Shi XD.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr 21; 30(2):516-521. PubMed ID: 35395989
    [Abstract] [Full Text] [Related]

  • 20. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
    Arcuri LJ, Nabhan SK, Cunha R, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Atta EH, de Oliveira JSR, Funke VAM, Loth G, Junior LGD, Paz A, Calixto RF, Gomes AA, Araujo CES, Colturato V, Simoes BP, Hamerschlak N, Flowers ME, Pasquini R, Rocha V, Bonfim C.
    Biol Blood Marrow Transplant; 2020 Dec 21; 26(12):2311-2317. PubMed ID: 32949751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.